Adipose tissue malfunction leads to altered adipokine secretion which might consequently
contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus …

Adipokines play a significant role in cardiometabolic diseases. Asprosin, a newly discovered
adipokine, was first identified as a glucose-raising protein hormone. Asprosin also …

Fibrillin-1 is a major component of the extracellular microfibrils, where it interacts with other
extracellular matrix proteins to provide elasticity to connective tissues, and regulates the …

Background and Objectives: Insulin resistance is a major contributor to the development of
type 2 diabetes and can be assessed using indirect indicators calculated from non-invasive …

ABSTRACT Background & Aims Asprosin is a promising candidate for novel treatments for
metabolic–endocrine disorders. The objective of this systematic review and meta-analysis …

Adipocytes regulate the body's metabolism by secreting adipokines to maintain energy
homeostasis. Asprosin is a new type of adipokine, and its relationship with obesity remains …

Background and purpose Asprosin was discovered as a new endocrine hormone originating
from fibrillin-1 cleavage that plays a crucial role in various metabolic-related diseases, such …

Ferroptosis is a type of non-apoptotic regulated cell death characterized by iron
accumulation and lipid peroxidation. Cisplatin is an effective chemotherapy drug with …

Objective To explore the association between serum asprosin and diabetic nephropathy
(DN) in patients with type 2 diabetes mellitus (T2DM) in the community. Methods In this cross …

Introduction Metabolic syndrome (MS) has a high prevalence in hemodialysis patients. High
asprosin levels are associated with the accumulation of adiposity and an increase in body …